Importantly, the development of neutralizing anti-IFNα autoAbs can have long-term consequences, as demonstrated by the observation of severe COVID-19 susceptibility in several individuals over a decade after the first detection of IFNα neutralization. The gene discussed is IFNA1; the disease is COVID-19.